drugset / Trial / NCT06158230

Comparison of Efficacy Between Combination of Amitriptyline-propranolol and Pizotifen for Migraine Prophylaxis.

NCT06158230

RandomizedParallel-groupTriple-blindPrevention

Summary

The goal of this clinical trial is to compare efficacy and observe common adverse effects of a combination of amitriptyline-propranolol and pizotifen as prophylactic treatments for migraine. The main question it aims to answer is: • Does pizotifen more effective than the combination of amitriptyline-propranolol in migraine prophylaxis? Participants will be asked to : * Maintain the provided headache diary accordingly * Take supplied drugs as described during clinical visits * Contact principle investigator if there is any issues regarding drug use and/or their adverse effects

Timeline

Start
2023-03-19
Primary completion
2023-11-25
Completion
2024-01-15

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amitriptyline Small molecule 25 mg
Subject Pizotifen Small molecule 1.5 mg
Comparator Propranolol Small molecule 40 mg

Indications